GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ChemoMetec AS (LTS:0DZ0) » Definitions » Other Income (Expense)

ChemoMetec AS (LTS:0DZ0) Other Income (Expense) : kr-0.3 Mil (TTM As of Dec. 2024)


View and export this data going back to 2007. Start your Free Trial

What is ChemoMetec AS Other Income (Expense)?

ChemoMetec AS's other income expense for the ChemoMetec AS's pretax income for the six months ended in Dec. 2024 was kr0.0 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2024 was kr-0.3 Mil.

ChemoMetec AS Other Income (Expense) Historical Data

The historical data trend for ChemoMetec AS's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ChemoMetec AS Other Income (Expense) Chart

ChemoMetec AS Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.11 -3.29 1.96 -1.64 -0.27

ChemoMetec AS Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -1.65 - -0.27 -

ChemoMetec AS Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr-0.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ChemoMetec AS  (LTS:0DZ0) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

ChemoMetec AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ChemoMetec AS (LTS:0DZ0) » Definitions » Other Income (Expense)
Comparable Companies
OCSE:EMBLA OCSE:GN OCSE:SMSMED OCSE:VIRO OCSE:AMBU B ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE ZBH PODD XSWX:SOON SHSE:688271 TSE:7733
Traded in Other Exchanges
CHEMMc:UK CHEMM:Denmark CHY:Germany
Address
Gydevang 43, Allerod, DNK, 3450
Website
https://www.chemometec.com
ChemoMetec AS specializes in designing, developing, and producing instruments using patented technology in cell counting and evaluation. It is engaged in the manufacturing and marketing of analytical instruments used for quantitative analysis of cells in liquids. Its applications include Cell Analysis and counting of Mammalian Cells, Yeast Cells, and Sperm Cells. It provides platforms for the determination of viability and cell count of yeast, veterinary semen, mammalian cells, and somatic cells as well as image analysis. It has four segments instruments; consumables; services and others, and the majority of its revenue is generated from the Consumable segment.

ChemoMetec AS Headlines

No Headlines